Sepsis Clinical Trial
— MtiSSOfficial title:
Mitochondrial Function in Septic Patients
Verified date | January 2020 |
Source | Chiang Mai University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Aim #1 To investigate the prevalence, risk and correlation of the level of sepsis with
mitochondrial dysfunction in sepsis patients Aim 1.1 To investigate the prevalence of
mitochondria dysfunction among sepsis patients Aim 1.2 To investigate the risk associated
with mitochondrial dysfunction in sepsis patients.
Aim 1.3 To investigate the association between sepsis severity (SOFA scoring system) and the
degree of mitochondrial dysfunction Aim #2 To investigate the association of mitochondrial
dysfunction in sepsis with ScvO2, lactate and ∆PCO2 Aim 3.1 To investigate the therapeutic
efficacy of steroids on the improvement mitochondrial function in sepsis patients Aim 3.2. To
investigate the efficacy of steroids on the reduction mortality rate in sepsis patients with
norepinephrine-resistant hypotension
Status | Completed |
Enrollment | 20 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Adults (=18 years of age) 2. Diagnosis of sepsis within 1 hour after presentation to the emergency department: known or presumed infection and SOFA score > 2 (table1) 3. Norepinephrine-resistant hypotension (refractory hypotension and not response to norepinephrine dose = 0.5 mcg/k/min) Exclusion Criteria: 1. Known pregnancy 2. Primary diagnosis of: 1. acute cerebral vascular event 2. acute coronary syndrome 3. acute cardiogenic pulmonary edema 4. status asthmaticus 5. major cardiac arrhythmia (as part of primary diagnosis) 6. seizure 7. drug overdose 8. injury from burn or trauma 3. Hemodynamic instability due to active hemorrhage 4. Requirement for immediate surgery 5. Do-Not-Attempt-Resuscitation (DNAR) order 6. Advanced directives restricting implementation of the resuscitation protocol 7. Transferred from another in-hospital setting 8. Sepsis or septic shock is not final diagnosis 9. Known history of HIV infection with suspected or known Cluster of differentiation 4 (CD4) <100 /mm2 10. Contraindication to central venous catheterization 11. Contraindication to blood transfusion 12. Attending clinician deems aggressive resuscitation unsuitable 13. Known history of HIV infection with suspected or known CD4 <100 /mm2 14. Neurodegenerative disease (effected mitochondria function) 15. known case adrenal insufficiency or chronic steroid user (Patient in this group should receive Hydrocortisone) |
Country | Name | City | State |
---|---|---|---|
Thailand | Emergency Department, Faculty of Medicine, Chaing Mai University | Chiang Mai |
Lead Sponsor | Collaborator |
---|---|
Chiang Mai University |
Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To investigate the level of mitochondrial respiration after steroid administration | Mean level comparative of mitochondrial respiration* in "Hydrocortisone" and "No intervention" groups will be investigated at before, day 1 after and day 7 after administration of intervention. *Mitochondrial function are mitochondrial respiration (Oxygen consumption rate in basal respiration, adenosine triphosphate (ATP) production, maximal respiration, spare capacity, proton leak, and non-mitochondrial respiration; Report in picomole/min) |
7 days | |
Primary | To investigate the level of mitochondrial stress after steroid administration | Mean level comparative of mitochondrial stress* in "Hydrocortisone" and "No intervention" groups will be investigated at before, day 1 after and day 7 after administration of intervention. *Mitochondrial stress (mass of superoxide per mitochondrial mass) and oxidative phosphorylation in each complex (densitometric analysis by western blot) |
7 days | |
Primary | To evaluate survival in septic patients who have refractory shock after steroid administration | Evaluate survival comparison in "Hydrocortisone" and "No intervention" groups. In 28 days survival and survival analysis until 28 day. | 28 days | |
Secondary | To investigate risk factor (Age, underlying disease, number of organ dysfunction) correlation with the mitochondrial function in sepsis patients | Since there are many suspected cases of sepsis in the emergency department, mitochondrial function* measurements will be collected. Additionally, the correlation among sex, age, obesity, underlying symptoms, cause of infection, pathogen, onset of fever before emergency department (ED) visit. Correlation between mitochondrial function and each factor will be compare in percent, mean or median in each group. *Mitochondrial function are mitochondrial respiration (Oxygen consumption rate in basal respiration, ATP production, maximal respiration, spare capacity, proton leak, and non-mitochondrial respiration), mitochondrial stress (mass of superoxide per mitochondrial mass) and oxidative phosphorylation in each complex (densitometric analysis by western blot) |
since emergency department admission until blood examination was collected, up to 24 hours. | |
Secondary | To investigate severity level of sepsis (SOFA Score) correlation with the mitochondrial function in sepsis patients | Since there are many suspected cases of sepsis in the emergency department, mitochondrial function* measurements will be collected. SOFA score**when patient visiting ED. Correlation between mitochondrial function and SOFA score present in linear correlation. *Mitochondrial function are mitochondrial respiration (Oxygen consumption rate in basal respiration, ATP production, maximal respiration, spare capacity, proton leak, and non-mitochondrial respiration), mitochondrial stress (mass of superoxide per mitochondrial mass) and oxidative phosphorylation in each complex (densitometric analysis by western blot) **Sepsis-related organ failure assessment score, is used to track a person's status to determine the extent of a person's organ function. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems. Score range from 0 to 20, if SOFA score increase at least 2 points, sepsis will be diagnosis. |
since emergency department admission until blood examination was collected, up to 24 hours. | |
Secondary | To investigate the association of level of mitochondrial function in sepsis with central venous oxygen saturation (ScvO2) | The correlation between these physiologic/biomarkers and mitochondrial function* will be evaluated. ScvO2 separated in low, normal and high group (<70%, 70-80%, >80%). Each ScvO2 group calculate mitochondrial function in mean and analysis mean difference. *Mitochondrial function are mitochondrial respiration (Oxygen consumption rate in basal respiration, ATP production, maximal respiration, spare capacity, proton leak, and non-mitochondrial respiration), mitochondrial stress (mass of superoxide per mitochondrial mass) and oxidative phosphorylation in each complex (densitometric analysis by western blot) |
since emergency department admission until patient disposition form emergency department, up to 24 hours. | |
Secondary | To investigate the association of level of mitochondrial function in sepsis with serum lactate. | The correlation between these physiologic/biomarkers and mitochondrial function* will be evaluated. Serum lactate separated in normal and high group (<2 mmol/L and >=2 mmol/L), . Each serum lactate group calculate mitochondrial function in mean and analysis mean difference. *Mitochondrial function are mitochondrial respiration (Oxygen consumption rate in basal respiration, ATP production, maximal respiration, spare capacity, proton leak, and non-mitochondrial respiration), mitochondrial stress (mass of superoxide per mitochondrial mass) and oxidative phosphorylation in each complex (densitometric analysis by western blot) |
since emergency department admission until patient disposition form emergency department, up to 24 hours. | |
Secondary | To investigate the association of level of mitochondrial function in sepsis with venous-to-arterial carbon dioxide tension difference (delta PCO2). | The correlation between these physiologic/biomarkers and mitochondrial function* will be evaluated. Delta PCO2 in normal and high group (<6 mmHg, >=6mmHg). Each group of Delta PCO2 calculate mitochondrial function in mean and analysis mean difference. *Mitochondrial function are mitochondrial respiration (Oxygen consumption rate in basal respiration, ATP production, maximal respiration, spare capacity, proton leak, and non-mitochondrial respiration), mitochondrial stress (mass of superoxide per mitochondrial mass) and oxidative phosphorylation in each complex (densitometric analysis by western blot) |
since emergency department admission until patient disposition form emergency department, up to 24 hours. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |